Effects of ganglioside on working memory and the default mode network in individuals with subjective cognitive impairment: a randomized controlled trial
This randomized, double-blind, placebo-controlled trial examined whether the
administration of ganglioside, an active ingredient of deer bone extract, can improve working
memory performance by increasing gray matter volume and functional connectivity in the
default mode network (DMN) in individuals with subjective cognitive impairment. Seventy-
five individuals with subjective cognitive impairment were chosen to receive either
ganglioside (330 μ g/day or 660 μ g/day) or a placebo for 8 weeks. Changes in working …
administration of ganglioside, an active ingredient of deer bone extract, can improve working
memory performance by increasing gray matter volume and functional connectivity in the
default mode network (DMN) in individuals with subjective cognitive impairment. Seventy-
five individuals with subjective cognitive impairment were chosen to receive either
ganglioside (330 μ g/day or 660 μ g/day) or a placebo for 8 weeks. Changes in working …
Effects of ganglioside on working memory and the default mode network in individuals with subjective cognitive impairment: a randomized controlled trial.
JYJ Jeon YuJin, KBN Kim BinNa, JE Kim, BR Kim… - 2016 - cabidigitallibrary.org
This randomized, double-blind, placebo-controlled trial examined whether the
administration of ganglioside, an active ingredient of deer bone extract, can improve working
memory performance by increasing gray matter volume and functional connectivity in the
default mode network (DMN) in individuals with subjective cognitive impairment. Seventy-
five individuals with subjective cognitive impairment were chosen to receive either
ganglioside (330 µg/day or 660 µg/day) or a placebo for 8 weeks. Changes in working …
administration of ganglioside, an active ingredient of deer bone extract, can improve working
memory performance by increasing gray matter volume and functional connectivity in the
default mode network (DMN) in individuals with subjective cognitive impairment. Seventy-
five individuals with subjective cognitive impairment were chosen to receive either
ganglioside (330 µg/day or 660 µg/day) or a placebo for 8 weeks. Changes in working …
以上显示的是最相近的搜索结果。 查看全部搜索结果